Last Price
0.004
Today's Change
+0.001 (33.33%)
Day's Change
0.003 - 0.004
Trading Volume
1,520,598
Market Cap
15 Million
Shares Outstanding
3 Billion
Avg Volume
14,200,631
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.00
PE Ratio
-0.40
EPS
-0.01
Earnings Announcement
29-Aug-2024
Previous Close
0.00
Open
0.00
Day's Range
0.003 - 0.004
Year Range
0.0025 - 0.0085
Trading Volume
1,520,598
1 Day Change
33.33%
5 Day Change
14.29%
1 Month Change
0.00%
3 Month Change
-20.00%
6 Month Change
0.00%
Ytd Change
-42.86%
1 Year Change
-42.86%
3 Year Change
-87.50%
5 Year Change
-85.19%
10 Year Change
-98.18%
Max Change
-99.20%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.